A

Atara Biotherapeutics
D

ATRA

8.15600
USD
-0.48
(-5.56%)
قبل الجلسة·9.80000USD+1.64400(+20.16%)
حجم التداول
301
الربح لكل سهم
-1
العائد الربحي
-
P/E
-7
حجم السوق
73,486,963
أصول ذات صلة المقالات
المزيد

العنوان: Atara Biotherapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.